Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Neutra's operating income for the twelve months ending Oct 31, 2023 was -$253.49K. For fiscal 2023 it was -$297.68K. The highest annual figure on record is -$81.22K in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | -$297.68K | – |
| FY2022 | Jan 31, 2022 | -$583.58K | – |
| FY2021 | Jan 31, 2021 | -$478.67K | – |
| FY2020 | Jan 31, 2020 | -$394.25K | – |
| FY2019 | Jan 31, 2019 | -$1.71M | – |
| FY2018 | Jan 31, 2018 | -$163.68K | – |
| FY2017 | Jan 31, 2017 | -$370.73K | – |
| FY2016 | Jan 31, 2016 | -$1.04M | – |
| FY2015 | Jan 31, 2015 | -$635.87K | – |
| FY2014 | Jan 31, 2014 | -$965.90K | – |
| FY2013 | Jan 31, 2013 | -$308.06K | – |
| FY2012 | Jan 31, 2012 | -$81.22K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$52.73K | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$71.77K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$71.21K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$57.79K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$66.07K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$82.35K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$91.46K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$160.67K | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$175.11K | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$125.10K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$122.70K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$249.07K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$94.22K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$86.86K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$48.52K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$88.81K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$180.79K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$57.70K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$66.95K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$75.89K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$1.51M | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$62.35K | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$63.85K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$47.40K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$25.84K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$34.54K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$55.90K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$95.11K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$67.16K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$94.11K | – |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | -$114.35K | – |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | -$646.17K | – |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | -$143.97K | – |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | -$109.88K | – |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | -$136.01K | – |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | -$121.85K | – |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | -$164.00K | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | -$211.63K | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | -$138.39K | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | -$260.37K | – |
See a number that looks wrong?